Literature DB >> 17060957

Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Talmadge E King1.   

Abstract

The idiopathic interstitial pneumonias are a heterogeneous group of poorly understood diseases with often devastating consequences for those afflicted. Subclassification of the idiopathic interstitial pneumonia based on clinical-radiological-pathological criteria has highlighted important pathogenic, therapeutic and prognostic implications. The most critical distinction is the presence of usual interstitial pneumonia, the histopathological pattern seen in idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis has a worse response to therapy and prognosis. New insight into the pathophysiology of usual interstitial pneumonia suggests a distinctly fibroproliferative process, and antifibrotic therapies show promise. While the clinical and radiographic diagnosis of idiopathic interstitial pneumonias can be made confidently in some cases, many patients require surgical lung biopsy to determine their underlying histopathology. A structured, clinical-radiological-pathological approach to the diagnosis of the idiopathic interstitial pneumonias, with particular attention to the identification of idiopathic pulmonary fibrosis, insures proper therapy, enhances prognostication, and allows for further investigation of therapies aimed at distinct pathophysiology.

Entities:  

Mesh:

Year:  2004        PMID: 17060957      PMCID: PMC2263760     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  106 in total

1.  Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients.

Authors:  T Johkoh; N L Müller; Y Cartier; P V Kavanagh; T E Hartman; M Akira; K Ichikado; M Ando; H Nakamura
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.

Authors:  M P Keane; J A Belperio; T A Moore; B B Moore; D A Arenberg; R E Smith; M D Burdick; S L Kunkel; R M Strieter
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.

Authors:  S Nagai; M Kitaichi; H Itoh; K Nishimura; T Izumi; T V Colby
Journal:  Eur Respir J       Date:  1998-11       Impact factor: 16.671

4.  Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration.

Authors:  J De Meester; J M Smits; G G Persijn; A Haverich
Journal:  J Heart Lung Transplant       Date:  1999-06       Impact factor: 10.247

5.  Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.

Authors:  W A Wallace; S E Howie
Journal:  J Pathol       Date:  1999-03       Impact factor: 7.996

6.  Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.

Authors:  G Raghu; W C Johnson; D Lockhart; Y Mageto
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

7.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

8.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Authors:  R Ziesche; E Hofbauer; K Wittmann; V Petkov; L H Block
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

9.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.

Authors:  Z D Daniil; F C Gilchrist; A G Nicholson; D M Hansell; J Harris; T V Colby; R M du Bois
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

10.  Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.

Authors:  Vibha N Lama; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Qi Long; Susan Murray; Ella A Kazerooni; Barry H Gross; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-08-13       Impact factor: 21.405

View more
  2 in total

1.  Postoperative respiratory failure caused by acute exacerbation of idiopathic interstitial pneumonia.

Authors:  Takeshi Kubota; Akimasa Miyata
Journal:  J Anesth       Date:  2011-04-13       Impact factor: 2.078

2.  Classification and Pathological Diagnosis of Idiopathic Interstitial Pneumonia.

Authors:  Zhihua Chen; Wenqiang Huang; Yibo Song
Journal:  Comput Intell Neurosci       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.